ESOMEPRAZOLE ACTAVIS esomeprazole magnesium dihydrate 40mg enteric-coated tablet blister pack

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

esomeprazole magnesium dihydrate, Quantity: 43.5 mg

Disponível em:

Medis Pharma Pty Ltd

DCI (Denominação Comum Internacional):

esomeprazole magnesium dihydrate

Forma farmacêutica:

Tablet, enteric coated

Composição:

Excipient Ingredients: polysorbate 80; magnesium stearate; purified talc; purified water; crospovidone; self-emulsifying glyceryl monostearate; hyprolose; methacrylic acid - ethyl acrylate copolymer (1:1); hypromellose; calcium hydrogen phosphate dihydrate; sodium lauryl sulfate; triethyl citrate; mannitol; microcrystalline cellulose; propylene glycol; colloidal anhydrous silica; titanium dioxide; maltodextrin; iron oxide yellow; iron oxide red; polydextrose; medium chain triglycerides

Via de administração:

Oral

Unidades em pacote:

7, 15, 30, and 100 tablets

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Gastro-Oesophageal Reflux Disease (GORD) ,? treatment of erosive reflux oesophagitis ,? long-term management of patients with healed oesophagitis to prevent relapse ,? symptomatic treatment of gastro-oesophageal reflux disease (GORD) ,? Patients requiring NSAID therapy ,? short-term treatment of upper gastrointestinal symptoms associated with non-steroidal anti-inflammatory drug NSAID (non-selective and COX-2 selective) therapy. ,? healing of gastric ulcers associated with non-steroidal anti-inflammatory drug ,NSAID (non-selective and COX-2 selective) therapy,? prevention of gastric and duodenal ulcers associated with non-steroidal anti inflammatory drug NSAID (non-selective and COX-2 selective) therapy in patients at risk. ,Prevention of rebleeding of gastric or duodenal ulcers following treatment with IV Esomeprazole solution by intravenous infusion.,Pathological hypersecretory conditions including Zollinger-Ellison syndrome and idiopathic hypersecretion ,In combination with appropriate antibiotics for: ,? healing of duodenal ulcer associated with Helicobacter pylori ,? eradication of Helicobacter pylori in patients with active or healed peptic ulcer

Resumo do produto:

Visual Identification: Pink, oblong, biconvex, film coated tablet, with '40' engraved on one side.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 15 Months; Container Temperature: Store below 25 degrees Celsius

Status de autorização:

Licence status A

Data de autorização:

2013-12-11